In short, it restores balance not just hormonally, but emotionally and physically. That's why in 1999, approximately 27% of postmenopausal women took hormone replacement therapy. Then in 2002, a study called the Women's Health Initiative found that women taking hormone replacement therapy may have an increased risk of breast cancer diagnoses, not mortality, but diagnoses. The study was not statistically significant, but it triggered a media frenzy and led to the FDA applying unscientific black box warnings to all hormone replacement therapy products in 2003. (08:11–08:27)
CLAIM
Asserts that the Women's Health Initiative study found an increased risk of breast cancer diagnoses with hormone replacement therapy.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
